We are live on ! Find out more
MGRX icon

Mangoceuticals
MGRX

18 hedge funds and large institutions have $1.88M invested in Mangoceuticals in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

129% more capital invested

Capital invested by funds: $820K → $1.88M (+$1.06M)

64% more funds holding

Funds holding: 11 → 18 (+7)

Holders
18
Holders Change
+7
Holders Change %
+63.64%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.49M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$483K
3
IC
Ikarian Capital
Texas
+$224K
4
Jane Street
Jane Street
New York
+$77K
5
UBS Group
UBS Group
Switzerland
+$74.9K

Top Sellers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
-$62.4K
2
SPIA
Steward Partners Investment Advisory
New York
-$4.59K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1K
4
Bank of America
Bank of America
North Carolina
-$112
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$1.14M +$2.49M +1,536,000 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$362K +$483K +297,528 +155%
IC
3
Ikarian Capital
Texas
$102K +$224K +138,146 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$80.2K +$33K +20,348 +23%
Jane Street
5
Jane Street
New York
$35.2K +$77K +47,503 New
UBS Group
6
UBS Group
Switzerland
$34.2K +$74.9K +46,164 +1,538,800%
BFM
7
Boothbay Fund Management
New York
$28.4K +$62.3K +38,441 New
Northern Trust
8
Northern Trust
Illinois
$27.8K +$30.2K +18,622 +98%
ACA
9
Ackerman Capital Advisors
Texas
$25.5K – – –
VF
10
Virtu Financial
New York
$25K +$54.3K +33,462 New
SS
11
Sunbelt Securities
Texas
$8.88K +$8.11K +5,000 +71%
CAG
12
Csenge Advisory Group
Florida
$7.4K +$16.2K +10,000 New
Osaic Holdings
13
Osaic Holdings
Arizona
$2.13K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$741 +$1.63K +1,002 New
Morgan Stanley
15
Morgan Stanley
New York
$740 +$1.62K +1,000 New
FFO
16
Fortitude Family Office
Arizona
$280 +$613 +378 New
Bank of America
17
Bank of America
North Carolina
$79 -$112 -69 -39%
Citigroup
18
Citigroup
New York
$1 +$2 +1 New
XT
19
XTX Topco
Cayman Islands
– -$62.4K -28,514 Closed
SPIA
20
Steward Partners Investment Advisory
New York
– -$4.59K -2,094 Closed
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
– -$1K -451 Closed

MGRX Hedge Fund Activity: Q4 2025 in Review

18 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q4 2025, worth a combined $1.88M — up 129% from $820K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MGRX positions and 3 closed out — a net gain of 7 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $2.49M. The largest seller was XTX Topco, exiting entirely with an estimated $62.4K sold.

  • 18 institutional investors held Mangoceuticals (MGRX) as of Q4 2025, up from 11 in Q3 2025.
  • Funds reported $1.88M of Mangoceuticals stock for Q4 2025, up 129% quarter-over-quarter.
  • 10 funds opened new Mangoceuticals positions in Q4 2025 and 3 closed out, a net change of +7 holders.
  • The largest Mangoceuticals buyer in Q4 2025 was Armistice Capital, an estimated $2.49M added.
  • The largest Mangoceuticals seller in Q4 2025 was XTX Topco, an estimated $62.4K sold.

Based on aggregated 13F filings for Q4 2025.